Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Inhibitors of Gram-positive Cell Wall Synthesis

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...

Staphylococcal Skin Infections

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...

Antifungal Agents

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

Antibiotic Selection

Antibiotic Selection

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Gajurel et al. Arbovirus in Solid Organ Transplants: A Narrative Review of the Literature. <i>Viruses</i> 2024, <i>16</i>, 1778.

Viruses·2025

Same author

Arbovirus in Solid Organ Transplants: A Narrative Review of the Literature.

Viruses·2024

Same author

Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience.

Open forum infectious diseases·2024

Same author

Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase-Producing Escherichia coli Causing Fatal Bloodstream Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024

Same author

Informing Building Strategies to Reduce Infectious Aerosol Transmission Risk by Integrating DNA Aerosol Tracers with Quantitative Microbial Risk Assessment.

Environmental science & technology·2023

Same author

Use of biomarkers to individualize antimicrobial therapy duration: a narrative review.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2022

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Vancomycin: does it still have a role as an antistaphylococcal agent?

Stan Deresinski¹

¹Division of Infectious Disease and Geographic Medicine, Stanford University, Stanford, CA, USA. polishmd@stanford.edu

Expert Review of Anti-Infective Therapy

|June 6, 2007

Summary

Vancomycin may be an inferior antibiotic for Staphylococcus aureus infections, including methicillin-resistant strains (MRSA). Newer agents show potential superiority, necessitating further clinical trials to confirm vancomycin

More Related Videos

In Vivo Mouse Model of Spinal Implant Infection

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

Related Experiment Videos

Last Updated: Jul 14, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

In Vivo Mouse Model of Spinal Implant Infection

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

Area of Science:

Infectious Diseases
Pharmacology
Microbiology

Background:

Vancomycin's role as an antistaphylococcal agent is under review due to emerging alternatives.
Concerns exist regarding vancomycin's efficacy against Staphylococcus aureus, including methicillin-resistant strains (MRSA).

Purpose of the Study:

To reassess the clinical utility of vancomycin in treating Staphylococcus aureus infections.
To evaluate the comparative effectiveness of vancomycin against newer antistaphylococcal agents.

Main Methods:

Review of existing clinical evidence and trial data comparing vancomycin with alternative antibiotics.
Analysis of trends in Staphylococcus aureus susceptibility and resistance patterns.

Main Results:

Vancomycin demonstrates inferiority to semisynthetic penicillins for methicillin-susceptible S. aureus infections.
Evidence suggests vancomycin may be inferior to other agents for MRSA infections.
Reduced susceptibility and heteroresistance to vancomycin in S. aureus are noted, alongside poor tissue penetration.

Conclusions:

Current evidence suggests vancomycin may be an inferior therapeutic option for S. aureus infections.
Novel agents show promise, but definitive comparative trials are needed to establish their roles and vancomycin's place.
Further research, including high-dose vancomycin trials, is required to determine optimal treatment strategies.